1. Are surrogate markers adequate to assess cardiovascular disease drugs?;Temple;JAMA,1999
2. Rosiglitazone: A European regulatory perspective;Blind;Diabetologia,2011
3. European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn [niacin/laropiprant] [press release]. European Medicines Agency; 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_detail_001694.jsp&mid=WC0b01ac058004d5c1. Accessed September 30, 2014.
4. European Medicines Agency recommends suspension of marketing authorisation for sibutramine [press release]. European Medicines Agency; 2010. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000985.jsp&mid=WC0b01ac058004d5c1. Accessed September 30, 2014.
5. The European Medicines Agency recommends suspension of the marketing authorisation of Acomplia [rimonabant] [press release]. European Medicines Agency; 2008. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2009/11/news_detail_000244.jsp&mid=WC0b01ac058004d5c1. Accessed September 30, 2014.